Clinical Trials List
Protocol NumberRV-HCC-PI-0669
2011-10-13 - 2013-12-31
Phase II
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Ann-Lii Cheng Division of Hematology & Oncology
- Tiffany Ting-Fang Shih Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
55 participants
-
Global
55 participants
